1
2
Apr. 26, 2022 — Researchers managed to reduce chronic inflammation associated with multiple sclerosis in mice thanks to the administration of a type of lipid that mediates ...
Sep. 30, 2021 — Reactive electrophilic drugs like Tecfidera, approved for the treatment of relapsing multiple sclerosis, show a lot of potential but are also mystery. Scientists have now used an innovative chemical ...
Nov. 30, 2021 — A phase 3 clinical trial tested the safety and efficacy of teriflunomide, an oral immunomodulatory drug, in children with multiple sclerosis. Although the medication did not prevent disease relapses ...
June 15, 2023 — A new study has identified a treatment that could repair myelin in the cortex, undoing some of the damage caused by ...
Apr. 12, 2022 — A recent study has demonstrated efficacy for the behavioral intervention, EMOPRINT, for treating deficits of facial recognition in individuals with multiple sclerosis (MS). The study provides Class I ...
Feb. 18, 2022 — Researchers shed new light on how myelin loss might underpin aberrant brain activity which have been observed in people with multiple sclerosis. The study suggests that myelination, however patchy on ...
Oct. 6, 2022 — Researchers demonstrate the relationship between the rate of cognitive fatigue in MS and microstructural brain changes. The findings promise to advance development of clinical interventions for ...
Mar. 8, 2023 — A pilot trial tested the nasal administration of the drug Foralumab, an anti-CD3 monoclonal antibody. Investigators found evidence that the drug dampened the inflammatory T cell response and ...
Aug. 10, 2022 — Quality of life is a measure of a person's level of comfort, health and happiness. For people with multiple sclerosis (MS), a new study has found there are specific factors that may affect a ...
Jan. 22, 2021 — Scientists have uncovered new clues implicating a type of herpes virus as the cause of a central nervous system disease in monkeys that's similar to multiple sclerosis in people. By linking two ...
